---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-234001"
form_type: "8-K"
ticker: "KRRO"
cik: "0001703647"
company_name: "Korro Bio, Inc."
filed_at: "2025-10-08T23:59:59+00:00"
generated_at: "2026-05-17T04:19:32.168116+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Korro Bio CFO resigns; CEO takes interim CFO role

## Summary
- CFO Vineet Agarwal resigns effective Oct 17, 2025; will advise for 30 days.
- CEO Dr. Ram Aiyar named interim CFO in addition to CEO duties, no extra compensation.
- Separation benefits include 9 months base salary ($352,500), prorated FY2025 target bonus ($149,400), and extended option exercise through Mar 31, 2027.
- Departure is not related to any disagreement with management.

## SEC filing metadata
- accession: 0001193125-25-234001
- form_type: 8-K
- ticker: KRRO
- cik: 0001703647
- company_name: Korro Bio, Inc.
- filed_at: 2025-10-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703647/000119312525234001/0001193125-25-234001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703647/000119312525234001/krro-20251007.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-234001
- JSON: https://secwatch.observer/filing/0001193125-25-234001.json
- Plain text: https://secwatch.observer/filing/0001193125-25-234001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.